Viokace and Hydrochlorothiazide drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Viokace (pancrelipase (amylase;lipase;protease)) and Hydrochlorothiazide (hydrochlorothiazide). Common drug interactions include atrial fibrillation among females.

The phase IV clinical study analyzes what interactions people have when they take Viokace and Hydrochlorothiazide. It is created by eHealthMe based on reports of 12 people who take the same drugs from the FDA, and is updated regularly.

What is Viokace?

Viokace has active ingredients of pancrelipase (amylase;lipase;protease). eHealthMe is studying from 208 Viokace users. Check the latest studies of Viokace.

What is Hydrochlorothiazide?

Hydrochlorothiazide has active ingredients of hydrochlorothiazide. It is often used in high blood pressure. eHealthMe is studying from 182,195 Hydrochlorothiazide users. Check the latest studies of Hydrochlorothiazide.

eHealthMe: drug outcomes in the real world

eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.

On Sep, 02, 2026

12 people who take Viokace and Hydrochlorothiazide together, and have interactions are studied.

Viokace and Hydrochlorothiazide drug interactions.

What are the common drug interactions of Viokace and Hydrochlorothiazide, by gender? *:

female:

Atrial fibrillation (fibrillation of the muscles of the atria of the heart)
Pancreatic disorder
Ear neoplasm malignant (ear cancerous tumour)
Energy increased
Eye disorder
Headache (pain in head)
Nausea (feeling of having an urge to vomit)
Pruritus (severe itching of the skin)
Renal disorder (kidney disease)
Arthritis (form of joint disorder that involves inflammation of one or more joints)

male:

n/a

What are the common drug interactions of Viokace and Hydrochlorothiazide, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

n/a

40-49:

n/a

50-59:

n/a

60+:

Atrial fibrillation (fibrillation of the muscles of the atria of the heart)
Vertigo
Energy increased
Eye disorder
Headache (pain in head)
Nausea (feeling of having an urge to vomit)
Pruritus (severe itching of the skin)
Renal disorder (kidney disease)
Arthritis (form of joint disorder that involves inflammation of one or more joints)
Dysphonia (speech disorder attributable to a disorder of phonation)

What are the existing conditions these people have? *

Immunodeficiency Common Variable: 8 people, 66.67%
Hypogammaglobulinaemia (an abnormally low concentration of gamma globulin in the blood and increased risk of infection): 4 people, 33.33%
Primary Immunodeficiency Syndrome: 3 people, 25.00%
Pancreatic Disorder: 1 person, 8.33%

* Approximation only. Some reports may have incomplete information.

Do you take Viokace and Hydrochlorothiazide?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously